MXL vs OGN · rev $360.5M vs P/E 3.4, rev $6.40B
MaxLinear Inc (MXL) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported MXL revenue for 2024-12-31 was $360.5M. Net income was -$245.2M. Revenue was down 48.0% from 2023-12-31 to 2024-12-31. MXL currently screens at market cap $7.42B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
MXL currently screens at market cap $7.42B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the MXL and OGN stock pages for the full models.
Not investment advice.